Skip to main content

Griseofulvin Oral Presentations Shortage

Last Updated: August 6, 2020
Status: Resolved

Products Affected - Description
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 500 mg, bottle, 30 count, NDC 64980-0186-03 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 500 mg, bottle, 100 count, NDC 64980-0186-01 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 125 mg, bottle, 30 count, NDC 64980-0184-03 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 125 mg, bottle, 100 count, NDC 64980-0184-01 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 250 mg, bottle, 30 count, NDC 64980-0185-03 - discontinued
    • Griseofulvin oral tablet, Rising Pharmaceuticals, 250 mg, bottle, 100 count, NDC 64980-0185-01 - discontinued
Reason for the Shortage
    • Amneal has griseofulvin tablets available.
    • Cipla has griseofulvin suspension available.
    • Rising discontinued griseofulvin products.
    • Sandoz has griseofulvin tablets available.
    • Teva has griseofulvin suspension available.
Available Products
    • Griseofulvin oral suspension, Cipla USA, 125 mg/5 mL, 120 mL bottle, 1 count, NDC 69097-0361-08
    • Griseofulvin oral tablet, Sandoz, 500 mg, bottle, 100 count, NDC 00781-5515-01
    • Griseofulvin oral suspension, Teva, 125 mg/5 mL, 120 mL bottle, 1 count, NDC 00472-0013-04
    • Griseofulvin oral tablet, Amneal, 125 mg, bottle, 100 count, NDC 00115-1724-01

Updated

Updated August 6, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created July 18, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer